Hot Asian Companies To Watch For 2014

Google (NASDAQ: GOOG  ) is generating too many negative reviews from the first wave of Google Glass adopters, and its best course of action may be to nix the search giant’s first foray into wearable computing before it becomes a more expensive and embarrassing flop.

It’s not this weekend’s Saturday Night Live parody. The comedy show also poked fun at Yum! Brands putting out Doritos-dusted tacos last year, and that single introduction was credited with dramatically boosting sales at Taco Bell.

It’s not that the initial wave of critics are questioning if we really need glasses with computing functionality. When Apple (NASDAQ: AAPL  ) introduced the iPad three years ago, it was also originally panned by skeptics wondering if we really needed tablets.

Wearable computing is the real deal. It’s coming. However, the early successes have been the Pebble smart watch and Nike’s (NYSE: NKE  ) FuelBand fitness-tracking bracelet. These are devices that are conveniently worn around the wrist, and it’s where wearable computing will win its first battle.

Hot Asian Companies To Watch For 2014: Pinnacle Entertainment Inc.(PNK)

Pinnacle Entertainment, Inc. owns, develops, and operates casinos, and related hospitality and entertainment facilities in the United States. It operates casinos, such as L’Auberge du Lac in Lake Charles, Louisiana; River City Casino and Lumiere Place in St. Louis, Missouri; Boomtown New Orleans in New Orleans, Louisiana; Belterra Casino Resort in Vevay, Indiana; Boomtown Bossier City in Bossier City, Louisiana; and Boomtown Reno in Reno, Nevada. The company also operates River Downs racetrack in southeast Cincinnati, Ohio. As of May 26, 2011, it operated seven casinos and one racetrack. The company was formerly known as Hollywood Park, Inc. and changed its name to Pinnacle Entertainment, Inc. in February 2000. Pinnacle Entertainment, Inc. was founded in 1935 and is based in Las Vegas, Nevada.

Advisors’ Opinion:

  • [By Sean Williams]

    Time to make the switch
    If I could name a sector that I’d certainly tread lightly around considering that consumers are tightening their wallets, it would be the casino sector. Casino companies rely on loose wallets and vacations to drive profits. This is why I feel it could be the time to say goodbye to casino and race track operator Pinnacle Entertainment (NYSE: PNK  ) near its 52-week high.

  • [By Travis Hoium]

    What: Shares of Ameristar Casinos (NASDAQ: ASCA  ) and Pinnacle Entertainment (NYSE: PNK  ) fell as much as 11% today after the government brought into question the merger of the two companies.

  • [By Dan Radovsky]

    Pinnacle Entertainment (NYSE: PNK  ) has reached an agreement in principle with the Bureau of Competition of the Federal Trade Commission that would allow the company to complete its proposed acquisition of Ameristar Casinos (NASDAQ: ASCA  ) , Pinnacle announced today.

Hot Asian Companies To Watch For 2014: Brown-Forman Corp (BFB)

Brown-Forman Corporation, incorporated on October 19, 1933, primarily manufactures, bottles, imports, exports, markets, and sells a variety of alcoholic beverage brands. The Company’s principal brands are Jack Daniel’s Tennessee Whiskey, Jack Daniel’s Tennessee Whiskey, Pepe Lopez Tequilas, Jack Daniel’s Single Barrel, Woodford Reserve Bourbons, Jack Daniel’s Ready-to-Drinks, Canadian Mist Blended Canadian Whiskies, Jack Daniel’s Tennessee Honey, Chambord Liqueur, Jack Daniel’s Winter Jack Chambord Vodka, Gentleman Jack, Collingwood Canadian Whisky, Southern Comfort, Early Times Bourbon, Southern Comfort Ready-to-Drinks, Early Times flavored line extensions, Southern Comfort flavored line extensions, Early Times Kentucky Whisky, Finlandia Vodkas, Korbel California Champagnes, Finlandia Ready-to-Drinks, Little Black Dress Vodkas, Antiguo Tequila, Maximus Vodkas, el Jimador Tequilas, Old Forester Bourbon, el Jimador New Mix Ready-to-Drinks, Sonoma-Cutrer Wines, Herradura Tequilas, and Tuaca Liqueur.

The Company’s products are sold in more than 150 countries around the world. The Company’s international markets include Australia, the United Kingdom, Mexico, Germany, Poland, France, Russia, Japan, Turkey, Canada, Spain, Czech Republic, South Africa, Brazil and Italy.

The Company competes with Bacardi Limited, Beam Inc., Davide Campari-Milano S.p.A., Diageo plc, LVMH Moet Hennessy Louis Vuitton S.A., Pernod Ricard S.A., and Remy Cointreau S.A.

Advisors’ Opinion:

  • [By Laura Brodbeck]

    Wednesday

    Earnings Expected From: Christopher & Banks Corporation (NYSE: CBK), Brown Forman Corporation (NYSE: BFB), Express, Inc. (NYSE: EXPR), Avago Technologies (NASDAQ: AVGO) Economic Releases Expected: US nonfarm employment change, US trade balance, Canadian trade balance, US new home sales, US ISM non-manufacturing PMI

    Thursday

  • [By Seth Jayson]

    Brown-Forman (NYSE: BFB  ) reported earnings on June 5. Here are the numbers you need to know.

    The 10-second takeaway
    For the quarter ended April 30 (Q4), Brown-Forman met expectations on revenues and beat expectations on earnings per share.

Hot Asian Companies To Watch For 2014: The NASDAQ OMX Group Inc.(NDAQ)

The NASDAQ OMX Group, Inc. provides trading, clearing, exchange technology, securities listing, and public company services worldwide. It offers trading across various asset classes, including cash equities, derivatives, debt, commodities, structured products, and exchange traded funds; capital formation solutions; financial services and exchanges technology; market data products; and financial indexes, as well as clearing, settlement, and depository services. The company also provides broker services comprising technology and customized securities administration solutions, such as back-office systems to financial participants. In addition, it offers global listing services; technology solutions for trading, clearing, settlement, and information dissemination; and facility management integration, surveillance solutions, and advisory services, as well as develops and licenses NASDAQ OMX branded indexes, associated derivatives, and financial products. As of December 31, 2010 , a total of 2,778 companies listed securities on The NASDAQ Stock Market. The NASDAQ OMX Group supports the operations of approximately 70 exchanges, clearing organizations, and central securities depositories. The company was formerly known as The Nasdaq Stock Market, Inc. and changed its name to The NASDAQ OMX Group, Inc. in February 2008. The NASDAQ OMX Group, Inc. was founded in 1971 and is based in New York, New York.

Advisors’ Opinion:

  • [By Ben Levisohn]

    Shares of Nasdaq OMX Group (NDAQ) have dropped 3% to $35.84 at 2:42 p.m. today, while IntercontinentalExchange (ICE) has fallen 2.1% to $193.69 and CME Group (CME) is off 2% at $72.53.

  • [By Reuters]

    Richard Drew/AP NEW YORK — The U.S. stock market is rigged in favor of high-speed electronic trading firms, which use their advantages to extract billions from investors, according to Michael Lewis, author of a new book on the topic, “Flash Boys: A Wall Street Revolt.” High-frequency trading is a practice carried out by many banks and proprietary trading firms using sophisticated computer programs to send gobs of orders into the market, executing a small portion of them when opportunities arise to capitalize on price imbalances, or to make markets. HFT makes up more than half of all U.S. trading volume. The trading methods and technology that make HFT possible are all legal, and the stock exchanges HFT firms trade on are highly regulated. But Lewis said these firms are using their speed advantage to profit at the expense of other market participants to the tune of tens of billions of dollars. “They are able to identify your desire to buy shares in Microsoft (MSFT) and buy them in front of you and sell them back to you at a higher price,” Lewis, whose book is available Monday, said Sunday on the “60 Minutes” television program. “This speed advantage that the faster traders have is milliseconds, some of it is fractions of milliseconds,” said Lewis, whose books include “The Big Short” and “Moneyball.” Those milliseconds can be valuable, making it possible to send around 10,000 orders in the blink of an eye. Darting in and out of trades, HFT firms make just fractions of a penny per trade, but the sheer speed and volume of their trading activity allows those that are successful to make significant profits. Proponents of HFT argue that the presence of such firms makes it easier for all market participants to find buyers and sellers for their trades, and that the speed at which HFT firms can detect and take advantage of pricing imbalances between different markets and assets leads to smaller bid-ask spreads. But Brad Katsuyama, former head trader in New Y

  • [By Wallace Witkowski]

    Insurers such as Aflac Inc. (AFL) , Allstate Corp. (ALL) , Aetna Inc. (AET) , Cigna Corp. (CI)  and Prudential Financial Inc. (PRU)  will also report, along with exchange operators Nasdaq OMX Group Inc. (NDAQ)  and CME Group Inc. (CME) . 

Hot Asian Companies To Watch For 2014: MYR Group Inc.(MYRG)

MYR Group Inc., through its subsidiaries, provides electrical construction service in the continental United States. The company operates in two segments, Transmission and Distribution, and Commercial and Industrial. The Transmission and Distribution segment provides design, engineering, procurement, construction, upgrade, maintenance, and repair services. Its services include the construction and maintenance of high voltage transmission lines, substations, and lower voltage underground and overhead distribution systems; and emergency restoration services in response to hurricane, ice, or other storm related damages. This segment?s customers include investor-owned utilities, municipal utilities, cooperatives, federally-owned utilities, independent power producers, independent transmission companies, industrial facility owners, and other contractors. The Commercial and Industrial segment provides electrical contracting services for commercial and industrial construction in the western United States. It offers electrical contracting services for airports, hospitals, data centers, hotels, casinos, arenas, convention centers, manufacturing plants, processing facilities, and transportation control and management systems. This segment?s customers include general contractors, commercial and industrial facility owners, local governments, and developers. MYR Group Inc. was founded in 1891 and is headquartered in Rolling Meadows, Illinois.

Advisors’ Opinion:

  • [By Damian Illia]

    Finally, I always like to see one of the most important financial ratios applying to stockholders, the best measure of performance for a firm’s management: the return on equity. The ratio has decreased when compared to its ROE from the same quarter one year prior. This is a signal of major weakness. Moreover, it is worse than those shown in the table like Aegion Corporation (AEGN), EnerNOC Inc. (ENOC), MYR GroupInc. (MYRG) and Pike Corporation (PIKE).

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market’s best stocks, it’s worth checking up on your companies’ free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That’s what we do with this series. Today, we’re checking in on MYR Group (Nasdaq: MYRG  ) , whose recent revenue and earnings are plotted below.

Hot Asian Companies To Watch For 2014: Enzon Pharmaceuticals Inc. (ENZN)

Enzon Pharmaceuticals, Inc., a biotechnology company, engages in the research and development of therapeutics for cancer patients with unmet medical needs. The company?s drug-development programs utilize two platforms-Customized PEGylation Linker Technology and third-generation mRNA-targeting agents utilizing the Locked Nucleic Acid (LNA) technology. It currently holds four compounds in clinical development and multiple novel LNA targets in preclinical research. The company?s development product pipeline consists of PEG-SN38 compound that utilizes Customized Linker Technology, which is in Phase II clinical trials for the treatment of metastatic colorectal and breast cancer, as well as a Phase I trial for pediatric patients with cancer; and the Hypoxia-Inducible Factor-1 alpha antagonist in Phase I studies for the treatment of solid tumors and lymphoma. Its product line also comprises Survivin antagonist in Phase I study in pediatric patients with recurrent acute lymphoblas tic leukemia; Androgen Receptor antagonist, a validated target for the treatment of prostate cancer that is in a Phase I study in patients with castration-resistant prostate cancer; and rights to five compounds, including AR, HER3, beta-catenin, PI3KCA, and Gli2. Enzon Pharmaceuticals, Inc. was founded in 1981 and is headquartered in Piscataway, New Jersey.

Advisors’ Opinion:

  • [By Bryan Murphy]

    With just a quick glance at the company’s recent news (or lack thereof), Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) doesn’t look like anything all that special… or even trade-worthy. It only takes a brief look at the chart of ENZN, however, to conclude this stock – lack of new or not – has just become something trade-worthy, because the rest of the market has clearly started to fall back in love with it; there’s no telling at what price the love affair could end.

  • [By Monica Wolfe]

    Over the past week Seth Klarman (Trades, Portfolio) of The Baupost Group made one real time reduction; the guru reduced his holdings in Enzon Pharmaceutical (ENZN).  The guru cut his holdings in the company -43.6% by selling 3,353,595 shares of the company’s stock.  He sold these shares at an average price of $1.15 per share; the shares are still currently trading at around the same price.

  • [By Lisa Levin]

    Enzon Pharmaceuticals (NASDAQ: ENZN) shares fell 2.57% to touch a new 52-week low of $1.11. Enzon Pharmaceuticals shares have dropped 75.85% over the past 52 weeks, while the S&P 500 index has gained 24.92% in the same period.

  • [By Lisa Levin]

    Enzon Pharmaceuticals (NASDAQ: ENZN) shares tumbled 28.28% to reach a new 52-week low of $1.15. Enzon Pharmaceuticals shares have dropped 63.30% over the past 52 weeks, while the S&P 500 index has gained 28.75% in the same period.

Hot Asian Companies To Watch For 2014: Martin Midstream Partners L.P.(MMLP)

Martin Midstream Partners L.P. collects, transports, stores, and markets petroleum products and by-products in the United States Gulf Coast region. The company?s Terminalling and Storage segment owns or operates 27 marine shore based terminal facilities and 12 specialty terminal facilities that provide storage, processing, and handling services for producers and suppliers of petroleum products and by-products, lubricants, and other liquids, including the refining of various grades and quantities of naphthenic lubricants and related products. This segment also offers land rental services to oil and gas companies, and storage and handling services for lubricants and fuel oil. The Natural Gas Services segment is involved in the gathering and processing of natural gas, and distribution of natural gas liquids (NGLs). This segment owns 1 NGL pipeline; and 3 NGL supply and storage facilities, as well as has ownership interests in approximately 719 miles of gathering and transmis sion pipelines located in the natural gas producing regions of east Texas, Northwest Louisiana, the Texas Gulf Coast and offshore Texas and federal waters in the Gulf of Mexico. The Sulfur Services segment processes and distributes sulfur produced by oil refineries that is primarily used in the production of fertilizers and industrial chemicals. This segment own and operates 6 sulfur-based fertilizer production plants, and 1 emulsified sulfur blending plant that manufacture sulfur-based fertilizer products for wholesale distributors and industrial users; 1 sulfuric acid production plant that processes molten sulfur into sulfuric acid; and 1 ammonium sulfate production plant that processes sulfuric acid into ammonium sulfate. The Marine Transportation segment utilizes a fleet of 41 inland marine tank barges, 20 inland push boats, and 4 offshore tug barge units that transport petroleum products and by-products. The company was founded in 2002 and is based in Kilgore, Texas.

Advisors’ Opinion:

  • [By Robert Rapier]

    The index includes everything from behemoths like Enterprise Product Partners (NYSE: EPD) and Kinder Morgan Energy Partners (NYSE: KMP) down to a pair with market capitalizations under $1 billion in Martin Midstream Partners (NASDAQ: MMLP) and Navios Maritime Partners (NYSE: NMM). The total market cap of the index is $328 billion, and its one-, three- and five-year total returns are 20 percent, 48 percent and 194 percent. The index yield is 6 percent.

  • [By Alyssa Oursler]

    This mega-trend is hardly news, and it can be played from all angles. One especially promising option: Martin Midstream Partners (MMLP).

    This master limited partnership cleans up, stores and transports gas — essentially collecting a “toll” on the gas that passes through its pipelines, then passing most of that toll along to shareholders per its MLP status. The current result of that setup: a mouth-watering 6.7% yield.

Hot Asian Companies To Watch For 2014: Oak Ridge Energy Technologies Inc (OKME)

Oak Ridge Energy Technologies, Inc., formerly Oak Ridge Micro-Energy, Inc., incorporated on August 15, 1986, is a development-stage company. The Company licenses thin-film, solid-state batteries for industrial, government, and medical applications. The Company’s thin-film battery is rechargeable, lithium-based, and the active battery layers are thinner than common plastic wrap.

The Company’s batteries are intended for applications, such as wireless smart sensors, which operate in harsh environments, security cards, radio frequency identification (RFID) tags, semiconductor non-volatile memory chips, and implantable medical devices. Its prototype cells on ceramic substrates supplied to customers are 0.024 of an inch (0.62 millimeters) thick. Thin-film lithium and lithium-ion batteries are ideally suited for a variety of applications where a small power source is needed.

The Company competes with Infinite Power Solutions, Inc., Front Edge Techn ology, Inc., Cymbet Corporation, Teledyne Electronic Technologies, Excellatron and Planar Energy Devices, Inc.

Advisors’ Opinion:

  • [By CRWE]

    Today, OKME has surged (+6.67%) up +0.050 at $.800 with 10,090 shares in play thus far (ref. google finance Delayed: 10:52AM EDT July 18, 2013).

    Oak Ridge Micro-Energy, Inc. previously reported a strategic US $2.5M investment by Precept Fund Management SPC’s on behalf of Prescient Fund SP into the revitalised US battery company Oak Ridge Micro-Energy.

    Mr. Steve Barber, Principal of Precept Investment Management Limited, the investment manager of Precept Fund Management SPC said:

    “Globally the energy storage sector is projected to be a US$60 Billion market by 2020. Precept’s $2.5m placement into OKME is a strategic move by the fund to secure a significant share of this exciting company and the growth potential of the battery market. Our opinion is that OKME has a world leading technical and commercial team, a focused business development strategy and the reputation to be a key player in the US and global battery market. OKME is one of only two investment targets the Fund identified after an in-depth analysis of the energy storage market. The other is a Swiss battery company named Leclanche. Precept is a long-term, active participation, value investor, and we look forward to a long and rewarding relationship with OKME.”

  • [By CRWE]

    Today, OKME has shed (-7.69%) down -0.050 at $.600 with 2,446 shares in play thus far (ref. google finance Delayed: 9:56AM EDT July 15, 2013), but don’t let this get you down.

    Oak Ridge Micro-Energy, Inc. previously reported a strategic US $2.5M investment by Precept Fund Management SPC’s on behalf of Prescient Fund SP into the revitalised US battery company Oak Ridge Micro-Energy.

    Mr. Steve Barber, Principal of Precept Investment Management Limited, the investment manager of Precept Fund Management SPC said:

    “Globally the energy storage sector is projected to be a US$60 Billion market by 2020. Precept’s $2.5m placement into OKME is a strategic move by the fund to secure a significant share of this exciting company and the growth potential of the battery market. Our opinion is that OKME has a world leading technical and commercial team, a focused business development strategy and the reputation to be a key player in the US and global battery market. OKME is one of only two investment targets the Fund identified after an in-depth analysis of the energy storage market. The other is a Swiss battery company named Leclanche. Precept is a long-term, active participation, value investor, and we look forward to a long and rewarding relationship with OKME.”

Hot Asian Companies To Watch For 2014: UnitedHealth Group Incorporated(UNH)

UnitedHealth Group Incorporated provides healthcare services in the United States. Its Health Benefits segment offers consumer-oriented health benefit plans and services to national employers, public sector employers, mid-sized employers, small businesses, and individuals; and non-employer based insurance options for purchase by individuals. It also provides health and well-being services for individuals aged 50 and older; and for services dealing with chronic disease and other specialized issues for older individuals, as well as health plans for the beneficiaries of acute and long-term care Medicaid plans. This segment offers its services through a network of 730,000 physicians and other health care professionals, and 5,300 hospitals. Its OptumHealth segment provides health, financial, and ancillary services and products that assist consumers through personalized health management solutions; benefit administration, and clinical and network management; health-based financi al services; behavioral solutions; and specialty benefits, such as dental, vision, life, critical illness, short-term disability, and stop-loss product offerings. The company?s Ingenix segment offers database and data management services, software products, publications, consulting and actuarial services, business process outsourcing services, and pharmaceutical data consulting and research services. Its Prescription Solutions segment provides integrated pharmacy benefit management services comprising retail network pharmacy contracting and management, claims processing, mail order pharmacy services, specialty pharmacy, benefit design consultation, rebate contracting and management, drug utilization review, formulary management programs, disease therapy management, and adherence programs to employer groups, union trusts, managed care organizations, Medicare-contracted plans, Medicaid plans, and third party administrators. The company was founded in 1974 and is based in Minn e tonka, Minnesota.

Advisors’ Opinion:

  • [By Ben Levisohn]

    The Dow Jones Industrial Average rose 237.10 points, or 1.5%, to 16302.77 this week–its largest weekly gain since Feb. 14–after dropping 0.2% today. The S&P 500, meanwhile, gained 1.4% to 1,866.52. United Health (UNH) rose 7.5% to $81.34 this week, while Microsoft (MSFT) advanced 6.5% to $40.16, the help lead the Dow higher.

  • [By Dan Dzombak]

    UnitedHealth Group (NYSE: UNH  )  was pulling the Dow Jones up with a 2.8% rise to $80.18. Health care is the only sector in the S&P 500 up for the day, rising 0.3%.

Hot Asian Companies To Watch For 2014: China Distance Education Holdings Ltd (DL)

China Distance Education Holdings Limited (CDEL), incorporated on January 11, 2008, offers a range of online education and test preparation courses and other related services and products. The Company operates and manages its business in the provision of online and offline education services and selling of related products. The Company’s online courses are designed to help professionals and other course participants obtain and maintain the skills, licenses and certifications necessary to pursue careers in China in the areas of accounting, law, healthcare, construction engineering and other industries. In addition, the Company also offers online foreign language courses. As of September 30, 2012, the Company operated 17 websites, including its main Website www.cdeledu.com and 16 other websites. The Company’s online courses feature audio-video lectures delivered through the Internet using streaming media and other Internet-based technologies, and are supplemented by text books, tutoring, online assignments and exercises, mock examinations, and other forms of learning activities and course-related support.

The Company sell books and reference materials through third-party bookstores and distributors across China, and, to a lesser extent, through its online bookstore and its offices in Beijing. In addition, it also offers offline business start-up training courses and in-person accounting and healthcare professional training to accounting firms and the general public. The Company provides course production services and platform production services for certain customers at their request.

Online Education Services

The Company offers online courses through its websites designed to help course participants obtain and maintain the skills, licenses and certifications necessary to pursue their careers and professions in China. Its online professional education courses cover a range of industries, includi ng accounting, law, healthcare, construction engineering and! others. It also offers online test preparation courses to self-taught learners pursuing higher education diplomas or degrees and to secondary school and college students for various academic and entrance exams. Additionally, the Company offers online foreign language courses.

The Company’s courses feature audio-video lectures by experienced lecturers or practitioners within their respective fields delivered through a multimedia and interactive Web interface using streaming media and other Internet-based technologies. Its online lectures are supplemented by textbooks, tutoring, online assignments, exercises, mock examinations, and other forms of learning activities and course-related support. Course participants using different platforms, including smart phones, tablets or regular computers, are able to access its courses through the Internet at times and places convenient for them.

The Web page also provides hyperlinks allowing course participants to access o ther useful functions during the lecture. It also provides its course lectures in the form of downloadable media files that allow course participants to save copies of the lectures onto their own personal computers and to play them offline. The Company utilizes digital rights management, or digital rights management (DRM), technology to restrict the transfer and viewing of downloadable media files.

Professional Course Offerings

The Company’s professional course offerings include accounting Courses, legal courses, healthcare courses, construction engineering courses, online information technology courses and other professional education courses. The Company offer courses relating to China’s important nationwide legal examination, the National Judicial Examination. It offers courses relating to three nationwide healthcare exams: the National Practicing Medical Doctor Qualification Examination, the Healthcare Professional Technical Qu alification Examination jointly administered by the Ministry! of Healt! h and the MOP and the National Pharmacist Qualification Examination administered by the MOP and the State Administration of Drug Supervision. It offers courses mainly relating to exams: Associate Constructor and Constructor Qualification Examinations, Construction Supervisor Qualification Examination, Construction Pricing Engineer Qualification Examination, Certified Safety Engineer Qualification Examination, Consulting Engineer Qualification Examination and Real Estate Appraiser Qualification Examination The Company provides professional education courses in the areas of information technology, securities and various civil service positions.

Higher Education for Self-Taught Learners

The Company through its Website www.zikao365.com offers courses targeted at self-taught learners pursuing associate diplomas or bachelor’s degrees in various academic areas. They complete their self study and obtain government accredited diplomas or deg rees by passing the Higher Education Examination for Self-Taught Learners administered by the MOE without having to enroll in and physically attend a traditional college or university. It offer test preparatory courses to help self-taught learners pass the requisite exams.

Academic Exam Preparation and Foreign Language Courses Study Courses

The Company through its Website www.cnedu.cn Website, the Company offer test preparation courses targeted at university students intending to take nationwide graduate school entrance exams in various disciplines administered by the MOE. It also operates websites focused on the secondary and college education market, foreign language study and other subjects. Its secondary education courses are designed to provide an online resource for secondary school course participants to prepare for these exams.

Other Products and Services

The Company sells books and reference m aterials relating to various professional courses and exam s! ubjects. ! To promote the use of its online courses, the Company also sells books and reference materials related to its courses such as the Elementary Level and Intermediate Level Accounting Professional Qualification Examination, the CPA Qualification Examination, the Registered Tax Agent Qualification Examination, the Certified Asset Appraiser Qualification Examination, the Accounting Professional Qualification Examination, accounting continuing education, the National Judicial Examination, the National Practicing Medical Doctor Qualification Examination, the Construction Supervisor Qualification Examination, the Constructor Qualification Examination, the Construction Pricing Engineer Qualification Examination, and the Intermediate Economist Qualification Examination.

The Company provides primary and secondary school supplementary tutoring services to students in a range of subject areas, such as Chinese, math and science. Students may attend offline courses taught by i ts in-person lecturers or view pre-recorded video courses on its Website at www.g12e.com. Its offline classes are available in Beijing and are subscribed during winter and summer breaks. It also provides course production services to certain customers on a contractual basis.

Regular, Premium and Elite Classes

The Company offer regular, premium and elite classes, which include foundation classes, intensified focus classes, exam Questions analysis classes and crash-course classes. It offers elite classes to legal practitioners, self-taught learners pursuing higher education diplomas or degrees, and professionals in the healthcare, construction engineering and other industries. Its foundation classes contain detailed instructions and content to provide course participants with a broad and comprehensive knowledge base relating to a specific subject area. Its intensified focus classes are designed to provide more intensive instructions focu sed on important topics in a specific subject area at a more! advanced! pace to course participants who already have basic knowledge of the subject area. Its exam questions analysis classes contain materials and instructions tailored specifically to preparation for the actual exams and the types of questions and topics that come up in each exam. Its crash-course classes are designed to provide a quick review of critical topic areas for specific exam subjects to enable course participants to make final preparations in the weeks prior to an exam. Its exam simulation system offers a wealth of mock test questions developed based on real tests, closely conforms to the syllabus and test requirements, and fully covers various key examination points.

Advisors’ Opinion:

  • [By Louis Navellier]

    NDZ returned to profit this year, and huge earnings increases are expected next year. The rapid improvement in fundamentals was noticed by Portfolio Grader back in September and the stock was upgraded to an “A.” NDZ stock is a “strong buy” at the current price.

    Great International Stocks: China Distance Education (DL)

    China Distance Education (DL) provides education services in the China. Its online courses are designed to help professionals and other course participants to obtain and maintain the skills, licenses, and certifications necessary to pursue careers in fields like accounting, law and engineering.

  • [By Louis Navellier]

    ABTL stock was upgraded to an “A” in Portfolio Grader back in July, and remains a “strong buy” as we head into the end of the year.

    ‘Best of the Best’ Stock Picks #2: China Distance Education Holdings (DL)

    China Distance Education Holdings (DL) provides education services in China.

Hot Asian Companies To Watch For 2014: Novartis AG (NVS)

Novartis AG, incorporated on February 29, 1996, provides healthcare solutions. The Company is a multinational group of companies specializing in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. Its portfolio includes medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. The Company has five segments: Pharmaceuticals, which include patent-protected prescription medicines; Alcon, which include surgical, ophthalmic pharmaceutical and vision care products; Sandoz, which include generic pharmaceuticals; vaccines and diagnostics, which include human vaccines and blood-testing diagnostics, and consumer health, which include over-the-counter medicines (OTC) and Animal Health. On April 8, 2011, the Company acquired the remaining non-controlling interest in Alcon, Inc. In December 2013, Alliance Pharma plc announced that its wholl y owned subsidiary, Alliance Pharmaceuticals Limited, acquired all the United Kingdom and Republic of Ireland (ROI) rights to Lypsyl from Novartis AG.

In April 2011, Novartis sells global rights to Elidel, a medicine to treat atopic dermatitis to Meda. In March 2011, Novartis completes acquisition of majority stake in Zhejiang Tianyuan vaccines company in China. In March 2011, the Company acquired Genoptix, Inc. In October 2011, Novartis discontinues development of AGO178 for depressive disorder. In December 2011, the Company discontinues development of PRT128 for acute coronary syndrome and chronic coronary heart disease, and SMC021 for osteoporosis and osteoarthritis. In April 2011, Alcon’s portfolio of generic ophthalmic medicines sold through its Falcon business unit primarily in the United States.

Pharmaceuticals Division

The Company’s Pharmaceuticals Division researches, develops, manufactures, distributes and sells patented pr escription medicines in the therapeutic areas, such as Oncol! ogy; Primary Care, consisting of Primary Care medicines and Established Medicines, and Specialty Care, consisting of Ophthalmology, Neuroscience, Integrated Hospital Care, and Critical Care medicines. The Pharmaceuticals Division is organized into global business franchises responsible for the commercialization of various products, as well as Novartis Oncology, a business unit responsible for the global development and commercialization of oncology products, and Novartis Molecular Diagnostics, a business responsible for the development and commercialization of diagnostic tests and services related to its pharmaceuticals portfolio and therapeutic areas.

The Company’s Oncology products include Afinitor/Votubia, Exjade, Sandostatin SC/Sandostatin LAR , Femara , Zometa, Tasigna and Gleevec/Glivec. Gleevec/Glivec, which is a signal transduction inhibitor approved to treat patients with certain forms of chronic myeloid leukemia (CML) and gastrointestinal stromal tu mors (GIST). Tasigna is a signal transduction inhibitor of the tyrosine kinase activity of Bcr-Abl, KIT+ and the PDGF-receptor. Zometa is a treatment to reduce or delay skeletal-related events (SREs), including pathologic fracture, spinal cord compression, and/or requirement of radiation therapy or surgery to bone, in patients with bone metastases (cancer that has spread to the bones) from solid tumors and multiple myeloma. Femara is a once-daily oral aromatase inhibitor for the treatment of early stage or advanced breast cancer in postmenopausal women. Sandostatin SC/Sandostatin LAR is indicated for the treatment of patients with acromegaly, a chronic disease caused by over-secretion of pituitary growth hormone in adults. Sandostatin is also indicated for the treatment of patients with certain symptoms associated with carcinoid tumors and other types of gastrointestinal and pancreatic neuroendocrine tumors. Exjade is an oral iron chelator approved for the treatment of chron ic iron overload due to blood transfusions in patients over ! two years! of age who have a range of underlying anemias. Patients with congenital and acquired chronic anemia, such as thalassemia, sickle cell disease and myelodysplastic syndromes, require transfusions, which puts them at risk of iron overload. Afinitor/Votubia is an oral inhibitor of the mTOR pathway.

The Company’s Primary Care products include Arcapta Neohaler/Onbrez Breezhaler, Diovan, Exforge, Tekturna/Rasilez, Galvus, Reclast/Aclasta, Voltaren/Cataflam, Ritalin, Ritalin LA, Focalin and Focalin XR. Its Specialty Care products include Lucentis, Gilenya, Exelon, Extavia and Comtan, and Stalevo. Its Integrated Hospital Care include Zortress/Certican, Ilaris, Neoral and Myfortic.The Company’s Critical Care products include Xolair and Tobi Podhaler. As of December 31, 2011, the products under development includes ACZ885, which is being investigated for the secondary prevention of cardiovascular events and for the treatment of Diabetes Mellitus; AEB071 (sotrastaurin) is a low molecular weight, selective inhibitor of protein kinase-C (PKC); AFQ056 (mavoglurant) is a metabotropic glutamate receptor 5 (mGluR5) antagonist in Phase II development for the treatment of Parkinson’s disease levodopa-induced dyskinesia; AIN457 (secukinumab) is a human monoclonal antibody neutralizing interleukin-17A, a key pro-inflammatory cytokine expressed by TH17 cells and other types of white blood cells; BAF312 is an oral, second-generation sphingosine 1-phosphate receptor modulator in Phase II development for relapsing-remitting multiple sclerosis; DEB025 (alisporivir) is a cyclophilin inhibitor for the treatment of Hepatitis C virus infection (HCV); Gileny a line treatment for relapsing forms of MS; Exjade (deferasirox) is an oral iron chelator in development for use in patients with non-transfusion-dependent thalassemia (NTDT); INC424 (ruxolitinib) is an investigational Janus kinase (JAK) inhibitor, and Zortress/Certican (everolimus) is an mTOR inhibitor with immune/non-immune cell proliferation inhibition being d! eveloped ! for prevention of solid organ transplant rejection.

Alcon Division

The Company’s Alcon Division discovers, develops, manufactures, distributes and sells eye care products. Alcon is engaged in eye care with product offerings in Surgical, Ophthalmic Pharmaceuticals and Vision Care. In Surgical, Alcon develops, manufactures, distributes and sells ophthalmic surgical equipment, instruments, disposable products and intraocular lenses. In Pharmaceutical, Alcon discovers, develops, manufactures, distributes and sells medicines to treat chronic and acute diseases of the eye, as well as over-the-counter medicines for the eye. In Vision Care, Alcon develops, manufactures, distributes and sells contact lenses and lens care products.

Alcon’s Surgical portfolio includes the Infiniti vision system for cataract procedures, the Constellation vision system for retinal operations, and the AcrySof family of intraocular lenses (IOLs), including the AcryS of IQ, AcrySof IQ ReSTOR, AcrySof IQ Toric and AcrySof IQ ReSTOR Toric IOLs. During the year ended December 31, 2011, its Alcon Division launched the LenSx femtosecond laser, a technology in cataract surgery, which increases the precision and reproductibility for corneal incisions, capsulorhexis and lens fragmentation steps of the procedure. In addition, Alcon provides advanced viscoelastics, surgical solutions, surgical packs and other disposable products for cataract and vitreoretinal surgery.

Alcon Division’s Ophthalmic Pharmaceuticals business combines Alcon’s range of pharmaceuticals with selected ophthalmic products (excluding Lucentis) previously marketed by the Novartis Pharmaceuticals Division. The products treat chronic and acute diseases of the eye including glaucoma and allergies, as well as anti-infective/anti-inflammatory and dry eye treatments. our Alcon Division’s Ophthalmic Pharmaceuticals portfolio include Travatan Z solution and DuoTrav soluti on for the treatment of elevated intraocular pressure associ! ated with! glaucoma; Vigamox solution for bacterial conjunctivitis; Pataday solution for ocular itching associated with allergic conjunctivitis; and Nevanac suspension for eye inflammation following cataract surgery. Alcon launched a number of products during 2011, including Dailies Total 1 lenses, Opti-Free EverMoist Multi Purpose Disinfecting Solution, LenSx laser, AcrySof IQ ReSTOR Toric lens, AcrySof IQ Toric T6-T9 lens, Travatan BAK-free solution, DuoTrav BAK-free solution, Moxeza solution and Systane Balance eye drops.

Sandoz Division

The Company’s Sandoz Division is a global generic pharmaceuticals company that develops, manufactures, distributes and sells prescription medicines, as well as pharmaceutical and biotechnological active substances, which are not protected by valid and enforceable third-party patents. The Sandoz Division has activities in Retail Generics, Anti-Infectives, and Biopharmaceuticals and Oncology Injectables. In Retail Generics , Sandoz develops, manufactures and markets active ingredients and finished dosage forms of pharmaceuticals, as well as supplying active ingredients to third parties. In Anti-Infectives, Sandoz develops and manufactures active pharmaceutical ingredients and intermediates, mainly antibiotics, for internal use by retail generics and for sale to third-party customers. In Biopharmaceuticals, Sandoz develops, manufactures and markets protein- or other biotechnology-based products (biosimilars or follow-on biologics) and sells biotech manufacturing services to other companies.

In Oncology Injectables, Sandoz develops, manufactures and markets primarily cytotoxic products for the hospital market. During 2011, the Company launched generic docetaxel (Taxotere), higher-strength generic amlodipine-benazepril (Lotrel), generic meropenem (Merem) injection, and the formation of a women’s health portfolio with generic Seasonale, Nordette, Yaz and Yasmin. The product launched in various European countries included generic docetaxel, ge! neric ana! strazole (Arimidex), and valsartan/covalsartan (an early entry generic version of Novartis Pharmaceuticals’ Diovan/Co-Diovan).

Vaccines and Diagnostics Division

The Company’s Vaccines and Diagnostics Division researches, develops, manufactures, distributes and sells preventive vaccines and diagnostic tools. Novartis Vaccines is a global developer and manufacturer of human vaccines. Novartis Diagnostics is a blood testing and molecular diagnostics business dedicated to preventing the spread of infectious diseases through blood-screening tools that protect the world’s blood supply. Novartis Vaccines’ products include influenza, meningococcal, pediatric, adult and travel vaccines.

The Company’s influenza vaccines include Agrippal, Fluad, Fluvirin and Optaflu. Its Meningococcal Vaccines includes Menjugate and Menveo. Its travel vaccines include Encepur Children, Encepur Adults, Ixiaro and Rabipur/Rabavert. Its Pediatric Vaccines includ e Polioral and Quinvaxem.

Consumer Health

Consumer Health consists of two Divisions: OTC (over-the-counter medicines) and Animal Health. Each has its own research, development, manufacturing, distribution and selling capabilities. OTC offers readily available consumer medicine. Animal Health provides veterinary products for farm and companion animals.

OTC (over-the-counter medicines) offers products for the treatment and prevention of common medical conditions and ailments. OTC business focuses on a group of global brands in product categories that include treatments for cough/cold/respiratory (Triaminic, Otrivin, TheraFlu/NeoCitran), pain relief (Excedrin, Voltaren), digestive health (Benefiber, Prevacid24HR, Pantoloc Control), dermatology (Lamisil, Fenistil), and smoking cessation (Habitrol/Nicotinell).

Animal Health offers products and services focusing on both companion and farm animals (including cultivated fish). Key products for c ompanion animals include Atopica (atopic dermatitis manageme! nt), Dera! maxx and Onsior (pain relief), Fortekor (heart failure in dogs, chronic renal insufficiency in cats), and Sentinel/Milbemax/Interceptor (intestinal parasite control and heartworm prevention), while farm animal products include the therapeutic anti-infective Denagard, an antimicrobial used to treat and control bacteria in swine, CLiK, an insect growth regulator used to control blowfly strike in sheep, cattle vaccines used to prevent respiratory and reproductive diseases in beef and dairy cattle, and Zolvix, a sheep drench representing the new sheep anthelmintic class. Aquaculture products include vaccines and treatments mainly used in salmon farming.

Advisors’ Opinion:

  • [By Sara Sjolin]

    The benchmark was lifted by a solid gain for Novartis AG (CH:NOVN)   (NVS) , up 3% after the drug maker said it will close its trial of a heart-failure drug early because of the strength of the results so far.

  • [By MONEYMORNING.COM]

    Almirall S.A. has helped develop the drug in Mexico and parts of Europe. A unit of Novartis AG (NYSE: NVS) is concentrating on parts of the Middle East, Africa, and Asia. And Bayer AG (OTC: BAYRY) has provided key support in Sativex’s development in the UK and Canada.

  • [By Jayson Derrick]

    Novartis’ (NYSE: NVS) Jakavi treatment has achieved its main goal in a Phase III trial of maintaining red-blood cell volume in patients with polycythemia vera, a deadly form of cancer. Shares lost 0.81 percent, closing at $83.14.

  • [By Patricio Kehoe]

    Johnson & Johnson (JNJ) comes in next, the fund owning over 235,000 shares, worth $21.5 million. The company operates in a highly competitive industry, including companies such as Novartis AG (NVS) and Pfizer Inc. (PFE). The company reported earnings per share increased by 32.5% compared to the same quarter one year prior, and has demonstrated a pattern of positive earnings per share growth over the past two years. The company returns cash to investors, and its current dividend yield is 2.83%, which is considered quite enough to protect the purchasing power.